![[Website of the National Cancer Institute's Technology Transfer Center. Partnering with Industry for Improved Public Health.]](/images/template/spacer.gif)
Carbon Nanotube Transistor -Based Microarray Binding Sensors
Background:
The National Cancer Institute's
Oncogenomics Section is seeking statements of capability or
interest from parties interested in collaborative research to
further develop, evaluate, or commercialize electronic detection of
nucleic acid and protein levels.
Description of
Technology:
This (more...)
(Full Text)
Intracellular RNA Sequencer
The National Cancer Institute,
Center for Cancer Research Nanobiology
Program seeks a research and development partner to develop a
single molecule sequencing device.
The Medusa(TM) Sequencer consists of a DNA or RNA
polymerase functionalized at (more...)
(Full Text)
Biomarker to Predict Resistance to Doxorubicin Cancer Therapy
Background:
The Laboratory of Human
Carcinogenesis, Center for Cancer Research, National Cancer
Institute, National Institutes of Health, is seeking statements of
capability or interest from parties interested in collaborative
research to further develop, evaluate, or (more...)
(Full Text)
High-Speed Parallel Molecular Nucleic Acid Sequencing
Background:
The NCI Nanobiology Program is
seeking statements of capability or interest from parties
interested in collaborative research to further develop, evaluate,
or commercialize nanoscale or molecular nucleic acid sequencing.
The IP is also available (more...)
(Full Text)
Nano-Sized Power Source for Implants & Medical Devices: an ATP-driven, Molecular Based Rotation Engine
The National Cancer Institute seeks CRADA partners to develop a
working model of a molecular-base rotation engine which is
constructed of two cylinders, one inner and one outer whose inner
surfaces are coated (more...)
(Full Text)
Molecular-Based Computing Device
Background:
NCI seeks partners to work with
the Laboratory of Experimental and Computational Biology to develop
a working prototype of this protein-based computer. This
collaboration is open for a multi-party collaboration where one
collaborator provides (more...)
(Full Text)
Antisera to Detect Phosphorylated Phosphoinositide-Dependent Kinase 1 (PDK-
Background:
The National Institutes of
Health, National Center for Complementary and Alternative Medicine,
Diabetes Unit is seeking statements of capability or interest from
parties interested in collaborative research to further develop,
evaluate, or commercialize phospho-specific (more...)
(Full Text)
Method For Efficient Delivery Of Proteins Into Cells
Background:
The National Cancer Institute's Protein Expression Laboratory is
seeking statements of capability or interest from parties
interested in collaborative research to further develop, evaluate,
or commercialize methods for delivery of proteins using virus-like
particles.
Proteins (more...)
(Full Text)
Molecular Motors Powered By Proteins
Background:
The National Cancer Institute
Center of Cancer Research Nanobiology Program is seeking statements
of capability or interest from parties interested in collaborative
research to further develop, evaluate, or commercialize the
Molecular Rotation Engine. The (more...)
(Full Text)
Imaging System for Correlative Electron/Confocal Fluorescence Microscopy
Background:
The National Cancer Institute's
Cell Biology Laboratory is seeking statements of interest or
capability from parties interested in collaborative research
agreements to further develop and commercialize a methodology and
device for the microscopic examination (more...)
(Full Text)
Novel Human IGF-I-Specific And IGF-I, IGF-II Cross-Reactive Antibodies As Potential Anti-Tumor Agents
Background:
The National Cancer Institute's Nanobiology Program is seeking
statements of capability or interest from parties interested in
collaborative research to further develop, evaluate, or
commercialize IGF-I-specific monoclonal antibodies.
A major drawback of current chemotherapy-based (more...)
(Full Text)
Uses of Cyanovirin-N for Anti-Hiv and Anti-Influenza Therapeutics and Prophylactics
T Cell Receptors that Recognize the Tyrosinase Tumor Antigen
Cancer Therapeutic Based on T Cell Receptors Designed to Regiospecifically Release Interleukin-12
TTC maintains an e-mail service to notify you of new Collaborative Opportunities. If you would like to receive these emails, please sign up below. If you'd like to unsubscribe you can use this form as well.